selected publications
-
academic article
- No evidence for cognitive decline or neurodegeneration in strain-matched GluN3A knockout mice. ALZHEIMERS & DEMENTIA. 4264-4266. 2023
- The apolipoprotein receptor LRP3 compromises APP levels. ALZHEIMERS RESEARCH & THERAPY. 1-17. 2021
-
congress communication
- NMDAR DISTRIBUTION AT SYNAPSES IN ALZHEIMER¿S HUMAN FRONTAL CORTEX 2023
- Synaptic vs Extrasynaptic NMDA receptors distribution in Alzheimer's human brain 2023
- Synaptic vs Extrasynaptic NMDAR distribution in Alzheimer¿s human brain 2023
- Acetylcholinesterase in iPS-derived cortical neurons from AD-patient 2022
- NMDA receptor and APOE in Alzheimer¿s disease: Searching for Connections 2022
- THE EXPRESSION OF THE LIPOPROTEIN RECEPTOR LRP3 IS INDUCED BY APOER2/REELIN AND IT IS ABLE TO REGULATEAPP 2022
- The apolipoprotein receptor LRP3 is regulated by ApoER2/reelin signalling and controls APP expression 2021
- The apolipoprotein receptor LRP3 is regulated by ApoER2/reelin signalling and controls APP expression 2021